# Perella Weinberg Partners: financial statements, quarterly

PWP · Nasdaq · CIK 1777835 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pwp.md) · [Financials](/companies/pwp/financials.md) · [Filings](/companies/pwp/filings.md) · [Insiders](/companies/pwp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pwp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [213 d](/filings/0001777835-26-000022.md) | [102](/filings/0001777835-25-000091.md) | [272](/filings/0001777835-25-000144.md) | [278](/filings/0001777835-25-000185.md) | [226 d](/filings/0001777835-26-000022.md) | [212](/filings/0001777835-26-000042.md) | [155](/filings/0001777835-26-000074.md) | [165](/filings/0001777835-26-000113.md) | [219 d](/filings/0001777835-26-000022.md) | [149](/filings/0001777835-26-000042.md) | [157](/filings/0001777835-26-000074.md) | [251](/filings/0001777835-26-000113.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(44.0) d](/filings/0001777835-26-000022.md) | [(53.6)](/filings/0001777835-25-000091.md) | [(82.2)](/filings/0001777835-25-000144.md) | [35.9](/filings/0001777835-25-000185.md) | [21.4 d](/filings/0001777835-26-000022.md) | [11.7](/filings/0001777835-26-000042.md) | [8.9](/filings/0001777835-26-000074.md) | [8.9](/filings/0001777835-26-000113.md) | [18.5 d](/filings/0001777835-26-000022.md) | [(12.9)](/filings/0001777835-26-000042.md) | [5.1](/filings/0001777835-26-000074.md) | [34.9](/filings/0001777835-26-000113.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(1.5) d](/filings/0001777835-26-000022.md) | [19.1](/filings/0001777835-25-000091.md) | [(0.6)](/filings/0001777835-25-000144.md) | [7.5](/filings/0001777835-25-000185.md) | [(4.9) d](/filings/0001777835-26-000022.md) | [(9.5)](/filings/0001777835-26-000042.md) | [2.0](/filings/0001777835-26-000074.md) | [3.0](/filings/0001777835-26-000113.md) | [8.0 d](/filings/0001777835-26-000022.md) | [(9.9)](/filings/0001777835-26-000042.md) | [(0.2)](/filings/0001777835-26-000074.md) | [11.9](/filings/0001777835-26-000113.md) |
| Net income | $m | [(10.4) d](/filings/0001777835-26-000022.md) | [(35.8)](/filings/0001777835-25-000091.md) | [(66.0)](/filings/0001777835-25-000144.md) | [16.4](/filings/0001777835-25-000185.md) | [20.8 d](/filings/0001777835-26-000022.md) | [17.3](/filings/0001777835-26-000042.md) | [2.7](/filings/0001777835-26-000074.md) | [6.0](/filings/0001777835-26-000113.md) | [9.4 d](/filings/0001777835-26-000022.md) | [1.5](/filings/0001777835-26-000042.md) | [5.3](/filings/0001777835-26-000074.md) | [17.6](/filings/0001777835-26-000113.md) |
| Diluted EPS | $ per share | not reported | [(0.91)](/filings/0001777835-25-000091.md) | [(1.21)](/filings/0001777835-25-000144.md) | [0.24](/filings/0001777835-25-000185.md) | not reported | [0.24](/filings/0001777835-26-000042.md) | [0.04](/filings/0001777835-26-000074.md) | [0.08](/filings/0001777835-26-000113.md) | not reported | [0.02](/filings/0001777835-26-000042.md) | [0.06](/filings/0001777835-26-000074.md) | [0.21](/filings/0001777835-26-000113.md) |
| Basic EPS | $ per share | not reported | [(0.73)](/filings/0001777835-25-000091.md) | [(1.21)](/filings/0001777835-25-000144.md) | [0.29](/filings/0001777835-25-000185.md) | not reported | [0.28](/filings/0001777835-26-000042.md) | [0.04](/filings/0001777835-26-000074.md) | [0.09](/filings/0001777835-26-000113.md) | not reported | [0.02](/filings/0001777835-26-000042.md) | [0.07](/filings/0001777835-26-000074.md) | [0.22](/filings/0001777835-26-000113.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [247](/filings/0001777835-25-000056.md) | [157](/filings/0001777835-24-000105.md) | [185](/filings/0001777835-24-000140.md) | [260](/filings/0001777835-24-000187.md) | [332](/filings/0001777835-26-000022.md) | [111](/filings/0001777835-25-000091.md) | [145](/filings/0001777835-25-000144.md) | [186](/filings/0001777835-25-000185.md) | [256](/filings/0001777835-26-000113.md) | [77.7](/filings/0001777835-26-000042.md) | [116](/filings/0001777835-26-000074.md) | [150](/filings/0001777835-26-000113.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [761](/filings/0001777835-25-000056.md) | [584](/filings/0001777835-24-000105.md) | [646](/filings/0001777835-24-000140.md) | [811](/filings/0001777835-24-000187.md) | [877](/filings/0001777835-26-000022.md) | [570](/filings/0001777835-25-000091.md) | [607](/filings/0001777835-25-000144.md) | [650](/filings/0001777835-25-000185.md) | [798](/filings/0001777835-26-000113.md) | [596](/filings/0001777835-26-000042.md) | [645](/filings/0001777835-26-000074.md) | [830](/filings/0001777835-26-000113.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [493](/filings/0001777835-25-000056.md) | [305](/filings/0001777835-24-000105.md) | [422](/filings/0001777835-24-000140.md) | [569](/filings/0001777835-24-000187.md) | [647](/filings/0001777835-26-000022.md) | [409](/filings/0001777835-25-000091.md) | [431](/filings/0001777835-25-000144.md) | [450](/filings/0001777835-25-000185.md) | [537](/filings/0001777835-26-000113.md) | [368](/filings/0001777835-26-000042.md) | [381](/filings/0001777835-26-000074.md) | [469](/filings/0001777835-26-000113.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [153](/filings/0001777835-25-000056.md) | [162](/filings/0001777835-24-000105.md) | [(283)](/filings/0001777835-24-000140.md) | [(361)](/filings/0001777835-24-000187.md) | [(421)](/filings/0001777835-25-000056.md) | [(323)](/filings/0001777835-26-000113.md) | [(318)](/filings/0001777835-26-000113.md) | [(302)](/filings/0001777835-26-000113.md) | [(127)](/filings/0001777835-26-000042.md) | [(155)](/filings/0001777835-26-000042.md) | [(45.8)](/filings/0001777835-26-000113.md) | [64.1](/filings/0001777835-26-000113.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [158 d](/filings/0001777835-26-000022.md) | [(206)](/filings/0001777835-25-000091.md) | [90.0 d](/filings/0001777835-25-000144.md) | [200 d](/filings/0001777835-25-000185.md) | [139 d](/filings/0001777835-26-000022.md) | [(177)](/filings/0001777835-26-000042.md) | [56.1 d](/filings/0001777835-26-000074.md) | [59.2 d](/filings/0001777835-26-000113.md) | [96.0 d](/filings/0001777835-26-000022.md) | [(110)](/filings/0001777835-26-000042.md) | [48.8 d](/filings/0001777835-26-000074.md) | [73.1 d](/filings/0001777835-26-000113.md) |
| Capital expenditure | $m | [12.1 d](/filings/0001777835-26-000022.md) | [8.5](/filings/0001777835-25-000091.md) | [6.3 d](/filings/0001777835-25-000144.md) | [1.0 d](/filings/0001777835-25-000185.md) | [0.7 d](/filings/0001777835-26-000022.md) | [1.0](/filings/0001777835-26-000042.md) | [0.8 d](/filings/0001777835-26-000074.md) | [1.5 d](/filings/0001777835-26-000113.md) | [1.0 d](/filings/0001777835-26-000022.md) | [2.1](/filings/0001777835-26-000042.md) | [1.7 d](/filings/0001777835-26-000074.md) | [2.1 d](/filings/0001777835-26-000113.md) |
| Dividends paid | $m | [3.1 d](/filings/0001777835-26-000022.md) | [4.8](/filings/0001777835-25-000091.md) | [3.9 d](/filings/0001777835-25-000144.md) | [7.0 d](/filings/0001777835-25-000185.md) | [4.7 d](/filings/0001777835-26-000022.md) | [8.3](/filings/0001777835-26-000042.md) | [4.4 d](/filings/0001777835-26-000074.md) | [5.5 d](/filings/0001777835-26-000113.md) | [4.6 d](/filings/0001777835-26-000022.md) | [8.6](/filings/0001777835-26-000042.md) | [6.3 d](/filings/0001777835-26-000074.md) | [7.8 d](/filings/0001777835-26-000113.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [86.6](/filings/0001777835-24-000105.md) | [86.5](/filings/0001777835-24-000140.md) | [86.6](/filings/0001777835-24-000187.md) | [90.5](/filings/0001777835-25-000091.md) | [54.6](/filings/0001777835-25-000144.md) | [69.8](/filings/0001777835-25-000185.md) | [75.8](/filings/0001777835-26-000042.md) | [98.8](/filings/0001777835-26-000074.md) | [100](/filings/0001777835-26-000113.md) | [101](/filings/0001777835-26-000042.md) | [102](/filings/0001777835-26-000074.md) | [103](/filings/0001777835-26-000113.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 13:58 ET. No prices; not investment advice.